Khiron Life Sciences Corp.

TSXV:KHRN.H Stock Report

Market Cap: CA$9.3m

Khiron Life Sciences Management

Management criteria checks 2/4

We currently do not have sufficient information about the CEO.

Key information

Alvaro Torres

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenure7.4yrs
CEO ownershipn/a
Management average tenure5.3yrs
Board average tenure6.2yrs

Recent management updates

Recent updates

Khiron Life Sciences Corp. (CVE:KHRN) Stock's 47% Dive Might Signal An Opportunity But It Requires Some Scrutiny

Apr 17
Khiron Life Sciences Corp. (CVE:KHRN) Stock's 47% Dive Might Signal An Opportunity But It Requires Some Scrutiny

We Think Shareholders Are Less Likely To Approve A Large Pay Rise For Khiron Life Sciences Corp.'s (CVE:KHRN) CEO For Now

Jun 24
We Think Shareholders Are Less Likely To Approve A Large Pay Rise For Khiron Life Sciences Corp.'s (CVE:KHRN) CEO For Now

We're Keeping An Eye On Khiron Life Sciences' (CVE:KHRN) Cash Burn Rate

May 03
We're Keeping An Eye On Khiron Life Sciences' (CVE:KHRN) Cash Burn Rate

What Type Of Returns Would Khiron Life Sciences'(CVE:KHRN) Shareholders Have Earned If They Purchased Their SharesYear Ago?

Feb 06
What Type Of Returns Would Khiron Life Sciences'(CVE:KHRN) Shareholders Have Earned If They Purchased Their SharesYear Ago?

CEO Compensation Analysis

How has Alvaro Torres's remuneration changed compared to Khiron Life Sciences's earnings?
DateTotal CompensationSalaryCompany Earnings
Sep 30 2022n/an/a

-CA$31m

Jun 30 2022n/an/a

-CA$30m

Mar 31 2022n/an/a

-CA$33m

Dec 31 2021CA$273kCA$189k

-CA$33m

Sep 30 2021n/an/a

-CA$16m

Jun 30 2021n/an/a

-CA$19m

Mar 31 2021n/an/a

-CA$20m

Dec 31 2020CA$346kCA$242k

-CA$24m

Sep 30 2020n/an/a

-CA$30m

Jun 30 2020n/an/a

-CA$34m

Mar 31 2020n/an/a

-CA$38m

Dec 31 2019CA$500kCA$255k

-CA$36m

Sep 30 2019n/an/a

-CA$35m

Jun 30 2019n/an/a

-CA$29m

Mar 31 2019n/an/a

-CA$26m

Dec 31 2018CA$425kCA$180k

-CA$20m

Sep 30 2018n/an/a

-CA$16m

Jun 30 2018n/an/a

-CA$12m

Mar 31 2018n/an/a

-CA$6m

Dec 31 2017n/an/a

-CA$5m

Compensation vs Market: Insufficient data to establish whether Alvaro's total compensation is reasonable compared to companies of similar size in the Canadian market.

Compensation vs Earnings: Insufficient data to compare Alvaro's compensation with company performance.

CEO

Alvaro Torres (45 yo)

7.4yrs

Tenure

CA$272,951

Compensation

Dr. Alvaro Francisco Torres, Ph D., M.Eng., M.Sc., serves as Chief Executive Officer of Electryon Power Inc. since January 2022. He is a Co-Founder of Khiron Life Sciences Corp. and has been its Chief Exec...

Leadership Team

NamePositionTenureCompensationOwnership
Alvaro Torres
Co-Founder7.4yrsCA$272.95kno data
Franziska Katterbach
President of Khiron Europe4.8yrsCA$385.66kno data
Swapan Kakumanu
Corporate Secretaryno dataCA$60.00kno data
Michael O'Connor
Chief Financial Officer1.3yrsno datano data
Manuel Buendia
Vice President of Operations5.8yrsno datano data
Marco Algorta
Country Manager of Uruguayno datano datano data

5.3yrs

Average Tenure

54yo

Average Age

Experienced Management: KHRN.H's management team is seasoned and experienced (5.3 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Alvaro Torres
Co-Founder6.2yrsCA$272.95kno data
Vicente Fox Quesada
Independent Director6yrsCA$180.53kno data
Alvaro Yanez
Independent Director6.2yrsCA$30.60kno data
Jairo Espinoza
Director of Jemarz S.A.S.no datano datano data

6.2yrs

Average Tenure

49.5yo

Average Age

Experienced Board: KHRN.H's board of directors are considered experienced (6.2 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/07/30 11:27
End of Day Share Price 2024/07/26 00:00
Earnings2022/09/30
Annual Earnings2021/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Khiron Life Sciences Corp. is covered by 4 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
David KideckelATB Capital Markets
Nikolaas FaesBryan Garnier & Co
Kimberly Thompson-HedlinCanaccord Genuity